Clinical trial Recruiting at 1 site Observational Ages 18 to 50

MRI study on neck pain in young and middle-aged adults

Official title: Applied Research on Young and Middle-aged Patients With Cervical Spondylotic Pain Using T2-mapping, T1ρ and Diffusion Kurtosis Imaging

Run by First Affiliated Hospital Xi'an Jiaotong University · NCT06217029 · Data updated 2026-11-12

This study is testing advanced MRI scans to see what causes neck and shoulder pain in young and middle-aged adults and how well non-surgical treatments work for them.

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexAll
Enrollment80 (estimated)
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
Academic / other
Locations1 site (Xi'an, Shaanxi)
StatusRecruiting
StartedJanuary 6, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedFebruary 26, 2024
Trial IDNCT06217029 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include young and middle-aged adults experiencing neck and shoulder pain for more than two months with evidence of cervical disc degeneration.

Probably not a fit

Patients with severe trauma, significant organic lesions, or chronic pain in other regions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the underlying causes of cervical and shoulder pain in young and middle-aged patients through advanced MRI techniques. Participants will undergo multiple MRI scans using T2-mapping, T1ρ, and DKI sequences, alongside clinical assessments, before and after receiving non-surgical treatments over a period of 12 months. The goal is to identify imaging predictors of treatment efficacy and better understand early disc degeneration that may not be visible on routine MRI. By analyzing the microstructural changes in the intervertebral discs, the study seeks to enhance the diagnosis and management of neck pain.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnostic methods and treatment strategies for patients suffering from neck pain.

How similar studies have gone: While there have been studies utilizing advanced MRI techniques for similar conditions, this specific approach focusing on early disc degeneration in young adults is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Neck and shoulder pain, with or without upper limb pain and numbness;
2. Disease duration longer than 2 months
3. Visual analogue score (VAS) ≥ 3
4. Cervical MRI showing cervical disc degeneration, bulge, protrusion, etc.
5. Patients will undergo non-surgical treatment (maxillary occipital traction, massage, etc.)

Exclusion Criteria:

1. Severe trauma and surgery in neck and shoulder region.
2. X-ray or CT showing the severe cervical spine hyperplasia, infection (suppurative, tuberculous), neoplasm (various primary and secondary tumors), rheumatic (rheumatoid arthritis, ankylosing spondylitis), and nuclei pulposus calcification.
3. Cervical MRI revealed organic lesions such as inflammation of the spinal cord, tumors, syringomyelia, etc.
4. Chronic pain in other regions.

Where it's running

  • The First Affiliated Hospital of Xi'an Jiaotong University
    Xi'an, Shaanxi, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.